Our day-to-day at Memorias del IICS

A glimpse into our day-to-day at the Memorias del IICS office

Leer más

About

Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud) is the official publication of the Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA), Paraguay. It publishes original scientific contributions in clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. Founded in 1983, the journal adopted its current name in 2002 and has been published exclusively online since 2015, incorporating XML article dissemination as of 2024. Since 2023, it operates under a continuous publication model. The journal accepts manuscripts in Spanish and English as original research articles, reviews, case studies, and brief communications. All content is available in open access, free of charge for authors and readers, under the Creative Commons Attribution 4.0 International License, in accordance with the Budapest Open Access Initiative (BOAI). It is indexed in BVS, SciELO Paraguay, HINARI, LILACS, DOAJ, Latindex, MIAR, Dialnet, CiteFactor, Google Scholar, LivRe, BASE, EBSCO, and Web of Science – SciELO Citation Index. The journal is funded by IICS-UNA, supports the OAI-PMH protocol for metadata harvesting, and uses the LOCKSS system for digital preservation of its contents.

 
Leer más

Peer Review Process

Manuscripts submitted to Memorias del Instituto de Investigaciones en Ciencias de la Salud undergo a double-blind peer review process, in which the identities of both authors and reviewers remain anonymous throughout the evaluation. Each manuscript is assessed by a minimum of two external reviewers with expertise in the relevant subject area, who are given a period of 30 days to submit their evaluation. Reviewers assess the originality, methodological rigor, scientific relevance, and clarity of presentation of each work. Based on the reviewers' reports, the Editorial Committee decides whether to accept, request revisions, or reject the manuscript, and communicates the decision to the authors as promptly as possible. This process ensures impartiality, transparency, and the scientific quality of published articles.

Leer más

Call for Papers

The Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA) invites researchers, academics, and health professionals to submit their manuscripts for consideration in the 2026 Volume of Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud). The journal accepts original and unpublished contributions in Spanish as original research articles, review articles, case studies, and brief communications, in the areas of clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. The call for submissions is open and ongoing, and manuscripts may be submitted at any time of the year through the journal's online submission system. All received manuscripts undergo double-blind peer review. The journal is open access, with no charges for authors or readers. For further information on submission guidelines, please refer to the author instructions available on the journal's website.

Leer más

Leucemia mieloide aguda con t(8; 21)(q22; q22). Reporte de casos

Authors

  • AF Espínola Cano
  • MS Rodríguez
  • Soledad Campos
  • JA Ferreira Nizza
  • J Noguera
  • Susy Figueredo Thiel

Keywords:

leucemia mieloide, translocación genética, análisis citogenético, pronóstico

Abstract

La leucemia mieloide aguda es una neoplasia hematopoyética caracterizada por la
proliferación clonal de blastos inmaduros en médulas ósea interfiriendo con sus funciones
normales. Tiene una supervivencia aproximada de 35% afectando principalmente a
adultos mayores de 60 años y niños menores de un año y preferentemente al sexo
masculino. Un hallazgo frecuente es la presencia de la translocación cromosómica t (8;
21) (q22; q22) que involucra a los genes RUNX1 y RUNX1T1. La detección de esta
alteración tiene implicancia diagnóstica y pronóstica de la enfermedad. El objetivo de este
trabajo es describir y reportar dos casos de leucemia mieloide aguda en pacientes
masculinos de 14 y 24 años que presentaron clínica, laboratorio y morfología típicos de la
enfermedad pero con edad de aparición no habitual, enfatizando además, el pronóstico
bueno desde el punto de vista citogenético de esta translocación en ambos casos.

Downloads

Download data is not yet available.

References

Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Hematología de Williams. 2a ed. Madrid: Marbán; 2007.

Kumar CC. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes & Cancer. 2011;2(2):95-107.

Rodak BF. Hematología: fundamentos y aplicaciones clínicas. 2a ed. Buenos Aires: Médica Panamericana; 2004.

Sans-Sabrafen J, Besses Raebel C, Vives Corrons J. Hematología clínica. 4a ed. Madrid: Harcourt; 2001.

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al: WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: Internacional Agency for Research on Cancer; 2008.

Mufti GJ, Flandrin G, Schaefer HE, Sandberg AA, Kanfer EJ. An atlas of Malignant Haematology:Cytology, Histology and Cytogenetics. Martin Dunitz Ltd. London; 1996.

Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N,et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality:frequent expression of immature B-cell antigen CD19 together with the stem cell antigen CD34.Blood. 1992;80:470–7.

Fröhling S, Scholl C, Gilliland DG, Levine RL. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol. 2005;23:6285-95.

Bakshi R, Zaidi SK, Pande S, Hassan MQ, Young DW, Montecino M et al. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes. J Cell Science. 2008;121:3981-90.

Elagib KE, Goldfarb AN. Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation. Cancer Lett. 2007; 251(2):179-86.

Blyth K, Cameron ER, Neil JC. The RUNX genes: gain or loss of function in cancer. Nature Rev.Cancer. 2005;5:376-87.

Schwieger M, Löhler J, Friel J, Scheller M, Horak I, Stocking C. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med. 2002;196:1227-40.

Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nature Rev. Cancer. 2007;7:233-45.

Bullinger L,ValK PJ. Gene Expression Profiling in Acute Myeloid Leukemia. J Clin Oncol.2005;23:6296-6305.

Martens JHA, Stunnenberg HG. The molecular signature of oncofusion proteins in acute myeloid leukemia. FEBS Lett. 2010;584:2662-9.

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J Clin. 2010;60;277-300.

Figueredo SJ. Diagnóstico citohistoquímico sistemático en biopsias de médula ósea y citologías hematológicas en el Paraguay. TRABAJO DE TESIS. Facultad de Ciencias Médicas. Universidad Nacional de Asunción. Revista Anales de la Facultad de Ciencias Médicas-UNA. 2005;1-2(38):9-21.

European Group for the Immunological characterization of leukemias (EGIL): Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of leukemias. Leukemia 1995;9:1783-6.

Da Silva G, Pilgerr D, De Castro S, Wagner S. Diagnostico laboratorial de leucemias mieloides

agudas. Bras Patol Med Lab 2006.v42 p 77-84.

Fröhling S, Döhner H. Chromosomal abnormalities in cáncer. N Engl J Med 2008;359:722-34.

Downloads

Published

2011-12-01

Issue

Section

Case report

How to Cite

Espínola Cano, A., Rodríguez, M., Campos, S., Ferreira Nizza, J., Noguera, J., & Figueredo Thiel, S. (2011). Leucemia mieloide aguda con t(8; 21)(q22; q22). Reporte de casos. Memorias Del Instituto De Investigaciones En Ciencias De La Salud, 9(2). https://revistascientificas.una.py/index.php/RIIC/article/view/1720